Year To Quarter End Statement Of Income

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7339470

Concept 2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
Year to quarter end statement of income
Statement of income
Net sales
JPY
1,000,000 JPY
140,000,000 JPY
1,236,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
906,000,000 JPY
259,000,000 JPY
1,000,000 JPY
1,167,000,000 JPY
1,167,000,000 JPY
JPY
Cost of sales
578,000,000 JPY
593,000,000 JPY
Gross profit (loss)
799,000,000 JPY
574,000,000 JPY
Selling, general and administrative expenses
584,000,000 JPY
729,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-207,000,000 JPY
-2,000,000 JPY
-64,000,000 JPY
489,000,000 JPY
214,000,000 JPY
421,000,000 JPY
215,000,000 JPY
-124,000,000 JPY
-5,000,000 JPY
-155,000,000 JPY
85,000,000 JPY
-241,000,000 JPY
Non-operating income
Interest income
8,000,000 JPY
4,000,000 JPY
Non-operating income
25,000,000 JPY
15,000,000 JPY
Non-operating expenses
Interest expenses
2,000,000 JPY
2,000,000 JPY
Non-operating expenses
10,000,000 JPY
102,000,000 JPY
Ordinary profit (loss)
229,000,000 JPY
-242,000,000 JPY
Extraordinary income
Extraordinary income
200,000,000 JPY
JPY
Profit (loss) before income taxes
429,000,000 JPY
-242,000,000 JPY
Income taxes - current
18,000,000 JPY
4,000,000 JPY
Income taxes - deferred
-61,000,000 JPY
-3,000,000 JPY
Income taxes
-42,000,000 JPY
1,000,000 JPY
Profit (loss)
472,000,000 JPY
-243,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.